Perspectum Releases New Whitepaper on The Cost-Effectiveness of Including Imaging in Phase 3 NASH Trials
October 20, 2020
Join a Patient Registry
October 13, 2020
New monitoring tool could be a positive change on the horizon for children with autoimmune hepatitis
October 06, 2020
Perspectum and UK Biobank help to uncover genetic marker associated with fatty liver disease
September 24, 2020
How to Choose an Imaging Provider for Your Clinical Trial
September 22, 2020
New non-invasive MRI biomarker for liver disease could cut costs for drug trials
Beyond the Biopsy
September 08, 2020
Perspectum Partners with UT Southwestern Medical Center on Dallas Heart & Minds Study
August 18, 2020
Multiparametric MRI: bridging the diagnostic gap for liver disease
August 07, 2020
